Screener Summaries Updates Institutions Sign In More Updates › Earnings › GRCE Earnings · Jun 18, 2026
Grace Therapeutics reports full-year revenue of $4.2M with net loss widening to $18.5M GRCE Grace Therapeutics, Inc.
Grace Therapeutics, Inc. issued a press release on June 18, 2026, announcing its financial results for the fiscal year ended March 31, 2026. The company is in the biotechnology/pharmaceutical industry and develops therapeutic solutions.
More from Grace Therapeutics, Inc. All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
